Windlas Biotech Q4 results: Shares peak amidst robust performanceWindlas Biotech Ltd reported revenue of ₹631 crores, marking a year-over-year growth of 23%. Find out more!
The Indian pharmaceutical sector is on a trajectory of robust growth, projected to burgeon to approximately $130 billion by the year 2030 and further...